Three-Year Interval Feasible for Stool-Based CRC Screening in Low-Risk People

TUESDAY, Dec. 6, 2022 (HealthDay News) -- A three-year interval for multitarget stool DNA (mt-sDNA) colorectal cancer (CRC) screening for those at average risk appears clinically appropriate, according to a study published online Oct. 7 in Cancer Prevention Research.
Thomas F. Imperiale, M.D., from the Indiana University School of Medicine in Indianapolis, and colleagues examined the clinical utility of a three-year interval for mt-sDNA testing. The analysis included 2,044 candidates for CRC screening whose providers prescribed the mt-sDNA test (April 2015 to July 2016), with participants testing positive completing a colonoscopy and those testing negative followed annually for three years.
The researchers found that at baseline, 13.9 percent had a positive mt-sDNA result and 86.1 percent were negative. Among the year 3 intention-to-screen cohort (591 with valid mt-sDNA and colonoscopy results), there were no CRCs and 63 advanced precancerous lesions (34.9 percent detected by mt-sDNA). Respective Predictive Summary Index values were 0 and 9.3 percent. For CRC, the observed three-year yield was lower than expected, while the yield for advanced precancerous lesions was higher than expected.
"The study findings suggest that repeat mt-sDNA screening at three years may be considered clinically appropriate, as evidenced by the reduced number of observed versus expected CRCs, while identifying advanced precancerous lesions at a rate consistent with the pivotal study," the authors write.
Several authors disclosed financial ties to Exact Sciences, which funded the study.
Related Posts
El cambio climático ya está dañando la salud de muchos estadounidenses, según un informe
VIERNES, 29 de octubre de 2021 (HealthDay News) -- El cambio climático ya está...
El uso de alucinógenos, como los hongos y el PCP, se duplicó entre los adultos jóvenes en unos años: estudio
VIERNES, 9 de junio de 2023 (HealthDay News) -- Los adultos jóvenes de EE. UU....
AHA News: Next Feat For Doc Who Gave CPR to 2 Runners in 1 Race? Preventing More Hearts From Stopping.
MONDAY, Feb. 20, 2023 (American Heart Association News) -- Running the Monterey...
Two Doses of BNT162b2 Vaccine Protect Against MIS-C
TUESDAY, Jan. 11, 2022 (HealthDay News) -- Receipt of two doses of the...